Table 1.
Clinical and histopathologic data (n = 102).
| Characteristic | Result |
|---|---|
| Median age (year) * | 71 (63–78) |
| Sex | |
| Male | 64 (62.7) |
| Female | 38 (37.3) |
| Median nodule size (mm) * | 25.5 (16.8–44.3) |
| Liver disease etiology | |
| Alcohol | 41 (40.2) |
| HBV | 30 (29.4) |
| HCV | 18 (17.6) |
| NASH | 13 (12.7) |
| Presence of cirrhosis | 81 (79.4) |
| Histopathologic analysis | 80 (78.4) |
| HCC | 37 (36.3) |
| Well-differentiated | 9 (24.3) |
| Moderately differentiated | 23 (62.2) |
| Poorly differentiated | 5 (13.5) |
| Metastasis | 26 (25.5) |
| ICC | 10 (9.8) |
| FNH | 5 (4.9) |
| Dysplastic nodule | 1 (1.0) |
| AML | 1 (1.0) |
| No histopathologic analysis | 22 (21.6) |
| Contrast-enhanced CT or MRI | |
| HCC | 15 (14.7) |
| Hemangioma | 7 (6.9) |
Note: Data are numbers of patient observations, with percentages in parentheses. * Data in parentheses are interquartile range. HBV = hepatitis B virus, HCV = hepatitis C virus, NASH = nonalcoholic steatohepatitis, HCC = hepatocellular carcinoma, ICC = intrahepatic cholangiocarcinoma, FNH = focal nodular hyperplasia, AML = angiomyolipoma, and y = year.